Arginine-methylated p53 is found in BC patients, and the methylation signal of p53 can be weakened by silencing PRMT1 with shRNA or inhibiting PRMT1 activity with specific inhibitors [44]. The gene discussed is PRMT1; the disease is breast cancer.